These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 18401314

  • 21. Risk Factors for Poor Quality of Life among Patients with Age-Related Macular Degeneration.
    Chatziralli I, Mitropoulos P, Parikakis E, Niakas D, Labiris G.
    Semin Ophthalmol; 2017; 32(6):772-780. PubMed ID: 27648680
    [Abstract] [Full Text] [Related]

  • 22. Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study.
    Caballe-Fontanet D, Alvarez-Peregrina C, Busquet-Duran N, Pedemonte-Sarrias E, Andreu-Vázquez C, Sánchez-Tena MÁ.
    Int J Environ Res Public Health; 2022 Jan 12; 19(2):. PubMed ID: 35055640
    [Abstract] [Full Text] [Related]

  • 23. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14.
    Childs AL, Bressler NM, Bass EB, Hawkins BS, Mangione CM, Marsh MJ, Miskala PH, Submacular Surgery Trials (SST) Research Group.
    Ophthalmology; 2004 Nov 12; 111(11):2007-14. PubMed ID: 15522365
    [Abstract] [Full Text] [Related]

  • 24. Assessment of vision-related quality of life and depression in patients with age-related macular degeneration.
    Dogan L, Tanriverdi D, Gungor K.
    Indian J Ophthalmol; 2024 Feb 01; 72(Suppl 2):S293-S297. PubMed ID: 38271426
    [Abstract] [Full Text] [Related]

  • 25. [Quality of life in patients with age-related macular degeneration - medical and social problem].
    Muzyka-Woźniak M, Misiuk-Hojło M, Wesolowska A.
    Klin Oczna; 2011 Feb 01; 113(4-6):161-4. PubMed ID: 21913448
    [Abstract] [Full Text] [Related]

  • 26. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA.
    Ophthalmology; 2005 Jan 01; 112(1):144-51. PubMed ID: 15629835
    [Abstract] [Full Text] [Related]

  • 27. Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration.
    Karadeniz Ugurlu S, Kocakaya Altundal AE, Altin Ekin M.
    Eye (Lond); 2017 Mar 01; 31(3):395-405. PubMed ID: 27813519
    [Abstract] [Full Text] [Related]

  • 28. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
    Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, Fine JT, Bressler NM.
    Invest Ophthalmol Vis Sci; 2011 May 18; 52(6):3354-9. PubMed ID: 21282568
    [Abstract] [Full Text] [Related]

  • 29. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P.
    Invest Ophthalmol Vis Sci; 2010 Feb 18; 51(2):712-7. PubMed ID: 19797233
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Gender Differences in Visual Functioning Questionnaire Scores among Patients with Age-Related Macular Degeneration.
    Sidhu S, Lynch AM, Mandava N, Manoharan N, Mathias MT, Patnaik JL.
    Ophthalmic Epidemiol; 2022 Jul 17; ():1-10. PubMed ID: 35848204
    [Abstract] [Full Text] [Related]

  • 33. Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss.
    Arias L, Armadá F, Donate J, García-Arumí J, Giralt J, Pazos B, Piñero A, Martínez F, Mondéjar JJ, Ortega I, Zlateva G, Buggage R.
    Eye (Lond); 2009 Feb 17; 23(2):326-33. PubMed ID: 18202712
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness model for neovascular age-related macular degeneration: comparing early and late treatment with pegaptanib sodium based on visual acuity.
    Javitt JC, Zlateva GP, Earnshaw SR, Pleil AM, Graham CN, Brogan AJ, Shah SN, Adamis AP.
    Value Health; 2008 Feb 17; 11(4):563-74. PubMed ID: 18179676
    [Abstract] [Full Text] [Related]

  • 37. Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration.
    Odergren A, Algvere PV, Seregard S, Libert C, Kvanta A.
    Acta Ophthalmol; 2010 Jun 17; 88(4):426-30. PubMed ID: 20597872
    [Abstract] [Full Text] [Related]

  • 38. Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes.
    Paulus YM, Jefferys JL, Hawkins BS, Scott AW.
    Qual Life Res; 2017 Aug 17; 26(8):2139-2151. PubMed ID: 28357680
    [Abstract] [Full Text] [Related]

  • 39. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F, Lafuma A, Berdeaux G.
    Invest Ophthalmol Vis Sci; 2007 Jan 17; 48(1):96-103. PubMed ID: 17197522
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.